C137H139Cl3F5N29O6 — CID 157067013
2-[(4-chloro-2-methyl-1H-inden-5-yl)oxy]-N-(3-cyclopropyl-2H-pyrrol-5-yl)-6-[4-(2-methoxyethyl)piperazin-1-yl]pyrimidin-4-amine;2-[(4-chloro-2-methyl-1H-inden-5-yl)oxy]-N-(3-methyl-2H-pyrrol-5-yl)-6-(4-phenylpiperazin-1-yl)pyrimidin-4-amine;2-[(4-chloro-2-methyl-1H-inden-5-yl)oxy]-N-(3-methyl-2H-pyrrol-5-yl)-6-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]pyrimidin-4-amine;N-(3-cyclopropyl-2H-pyrrol-5-yl)-2-[(4-fluoro-2-methyl-1H-inden-5-yl)oxy]-6-(4-phenylpiperazin-1-yl)pyrimidin-4-amine;2-[(4-fluoro-2-methyl-1H-inden-5-yl)oxy]-4-N-(3-methyl-2H-pyrrol-5-yl)pyrimidine-4,6-diamine (PubChem CID 157067013) has the molecular formula C137H139Cl3F5N29O6 and a molecular weight of 2489.16 g/mol. Its IUPAC name is 2-[(4-chloro-2-methyl-1H-inden-5-yl)oxy]-N-(3-cyclopropyl-2H-pyrrol-5-yl)-6-[4-(2-methoxyethyl)piperazin-1-yl]pyrimidin-4-amine;2-[(4-chloro-2-methyl-1H-inden-5-yl)oxy]-N-(3-methyl-2H-pyrrol-5-yl)-6-(4-phenylpiperazin-1-yl)pyrimidin-4-amine;2-[(4-chloro-2-methyl-1H-inden-5-yl)oxy]-N-(3-methyl-2H-pyrrol-5-yl)-6-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]pyrimidin-4-amine;N-(3-cyclopropyl-2H-pyrrol-5-yl)-2-[(4-fluoro-2-methyl-1H-inden-5-yl)oxy]-6-(4-phenylpiperazin-1-yl)pyrimidin-4-amine;2-[(4-fluoro-2-methyl-1H-inden-5-yl)oxy]-4-N-(3-methyl-2H-pyrrol-5-yl)pyrimidine-4,6-diamine.
| Compound Name | 2-[(4-chloro-2-methyl-1H-inden-5-yl)oxy]-N-(3-cyclopropyl-2H-pyrrol-5-yl)-6-[4-(2-methoxyethyl)piperazin-1-yl]pyrimidin-4-amine;2-[(4-chloro-2-methyl-1H-inden-5-yl)oxy]-N-(3-methyl-2H-pyrrol-5-yl)-6-(4-phenylpiperazin-1-yl)pyrimidin-4-amine;2-[(4-chloro-2-methyl-1H-inden-5-yl)oxy]-N-(3-methyl-2H-pyrrol-5-yl)-6-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]pyrimidin-4-amine;N-(3-cyclopropyl-2H-pyrrol-5-yl)-2-[(4-fluoro-2-methyl-1H-inden-5-yl)oxy]-6-(4-phenylpiperazin-1-yl)pyrimidin-4-amine;2-[(4-fluoro-2-methyl-1H-inden-5-yl)oxy]-4-N-(3-methyl-2H-pyrrol-5-yl)pyrimidine-4,6-diamine |
|---|---|
| PubChem CID | 157067013 |
| Molecular Formula | C137H139Cl3F5N29O6 |
| Molecular Weight | 2489.16 g/mol |
| Exact Mass | 2486.04 |
| IUPAC Name | 2-[(4-chloro-2-methyl-1H-inden-5-yl)oxy]-N-(3-cyclopropyl-2H-pyrrol-5-yl)-6-[4-(2-methoxyethyl)piperazin-1-yl]pyrimidin-4-amine;2-[(4-chloro-2-methyl-1H-inden-5-yl)oxy]-N-(3-methyl-2H-pyrrol-5-yl)-6-(4-phenylpiperazin-1-yl)pyrimidin-4-amine;2-[(4-chloro-2-methyl-1H-inden-5-yl)oxy]-N-(3-methyl-2H-pyrrol-5-yl)-6-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]pyrimidin-4-amine;N-(3-cyclopropyl-2H-pyrrol-5-yl)-2-[(4-fluoro-2-methyl-1H-inden-5-yl)oxy]-6-(4-phenylpiperazin-1-yl)pyrimidin-4-amine;2-[(4-fluoro-2-methyl-1H-inden-5-yl)oxy]-4-N-(3-methyl-2H-pyrrol-5-yl)pyrimidine-4,6-diamine |
| SMILES | CC1=CC(Nc2cc(N)nc(Oc3ccc4c(c3F)C=C(C)C4)n2)=NC1.CC1=CC(Nc2cc(N3CCN(c4cccc(C(F)(F)F)c4)CC3)nc(Oc3ccc4c(c3Cl)C=C(C)C4)n2)=NC1.CC1=CC(Nc2cc(N3CCN(c4ccccc4)CC3)nc(Oc3ccc4c(c3Cl)C=C(C)C4)n2)=NC1.CC1=Cc2c(ccc(Oc3nc(NC4=NCC(C5CC5)=C4)cc(N4CCN(c5ccccc5)CC4)n3)c2F)C1.COCCN1CCN(c2cc(NC3=NCC(C4CC4)=C3)nc(Oc3ccc4c(c3Cl)C=C(C)C4)n2)CC1 |
| InChI | InChI=1S/C31H31FN6O.C30H28ClF3N6O.C29H29ClN6O.C28H33ClN6O2.C19H18FN5O/c1-20-15-22-9-10-26(30(32)25(22)16-20)39-31-35-28(34-27-17-23(19-33-27)21-7-8-21)18-29(36-31)38-13-11-37(12-14-38)24-5-3-2-4-6-24;1-18-12-20-6-7-24(28(31)23(20)13-18)41-29-37-26(36-25-14-19(2)17-35-25)16-27(38-29)40-10-8-39(9-11-40)22-5-3-4-21(15-22)30(32,33)34;1-19-14-21-8-9-24(28(30)23(21)15-19)37-29-33-26(32-25-16-20(2)18-31-25)17-27(34-29)36-12-10-35(11-13-36)22-6-4-3-5-7-22;1-18-13-20-5-6-23(27(29)22(20)14-18)37-28-32-25(31-24-15-21(17-30-24)19-3-4-19)16-26(33-28)35-9-7-34(8-10-35)11-12-36-2;1-10-5-12-3-4-14(18(20)13(12)6-10)26-19-23-15(21)8-17(25-19)24-16-7-11(2)9-22-16/h2-6,9-10,16-18,21H,7-8,11-15,19H2,1H3,(H,33,34,35,36);3-7,13-16H,8-12,17H2,1-2H3,(H,35,36,37,38);3-9,15-17H,10-14,18H2,1-2H3,(H,31,32,33,34);5-6,14-16,19H,3-4,7-13,17H2,1-2H3,(H,30,31,32,33);3-4,6-8H,5,9H2,1-2H3,(H3,21,22,23,24,25) |
| InChIKey | ABZMDIALUZPWGH-UHFFFAOYSA-N |
| XLogP | 27.36 |
| TPSA | 358.17 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 35 |
| Rotatable Bonds | 27 |
| Heavy Atoms | 180 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2489.16 |
| LogP ≤ 5 | 27.36 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 35 |